The Italian Competition Authority fines anti-competitive practices aimed at delaying market entry for generic medicines (Pfizer)

Italy: The Competition Authority fines anti-competitive Practices aimed at delaying Market Entry for generic Medicines* On 11 January 2012, the Italian Competition Authority (ICA) sanctioned the multinational pharmaceutical group Pfizer (Pfizer) for a violation of Article 102 TFEU and imposed on it a fine amounting to € 10 677 706. In October 2010, following a complaint filed by the generic company Ratiopharm Italia S.r.l., the ICA opened proceedings against Pfizer (in particular against Pfizer Inc. and its subsidiaries Pfizer Italia S.r.l. and Pfizer Health A.B.) for an alleged infringement of Article 102 TFEU on the Italian market for

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

European Competition Network Brief, The Italian Competition Authority fines anti-competitive practices aimed at delaying market entry for generic medicines (Pfizer), 11 January 2012, e-Competitions Bulletin Pharma & Dominance, Art. N° 44834

Visites 278

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues